Icod2-bandeau

Program > Program

ICOD2 Draft Program 20pix_Icon_pdf_file.svg.png

 

 

Wednesday September, 25

14h00-17h00

Special interest groups meetings

 On demand. If your working group wants to meet, do not hesitate to inform us.

15h00-17h00 

Participants registration

 

20h00

Welcome reception

 

 

 

 

Thursday September, 26

8h00-9h00

Participants welcome and registration

 

9h00-10h30

Opening session

Main amphi (Bias 1)

Welcome opening speech

Opening keynote: title tbc (Barbara Farrell)

10h30-11h00

Break

 

11h00-12h30

Plenary Oral communications #1

Main amphi (Bias 1)

Impact of Deprescribing Initiatives, Guidelines and Policies From Around the World

12h30- 14h00

Lunch (Bias 1 hall)

 

14h00-15h30

Parallel sessions

 

 

Oral communications #2  

Main amphi (Bias 1)

Central Nervous System Active Medications: Opportunities for Deprescribing

 

Workshops (Bias 2)

 

 

Room 001

W1- Deprescribing Research: A Workshop Addressing Study Design, Measurement, and Implementation Challenges in Primary Care (Cynthia Boyd, Michael Steinman, Sandra Simmons)

 

Room 002

W2- Deprescribing Communication: Global summary and Application Opportunities (Robert Wahler, Na Ouyang, Danijela Gnjidic, Marcia Mecca, Ariel Green, Sarah Hilmer, Holly Holmes, Emily Reeve, Nancy Schoenborn, Ranjit Singh, Richard Street, Carmen Reyes, Sandra Ko, Terri Fried)

 

Room 003

W3- Integrating Deprescribing Competencies into Health Care Curricula: A “How To” Workshop (Barbara Farrell, Lalitha Raman-Wilms, Cheryl Sadowski, Emily G. McDonald)

15h30-16h30

Break – Poster session

(Bias 1 hall)

 

16h30- 17h30

First day closing keynote

Main amphi (Bias 1)

First day closing keynote: Title tbc (Georges Marcoux - David Gardner)

17h30-18h00

Departure of participants

 

20h00

Conference dinner

 

 

Friday September 27

8h00-9h00 

Participants welcome

 

9h00-10h30

Parallel sessions

 

 

Oral communications #3

Main amphi (Bias 1)

Deprescribing in the Real World: Learnings from Pharmacoepidemiology, Implementation Science, and Framework Development

 

Workshops (Bias 2)

 

 

Room 001

W4- Developing and implementing team-based deprescribing actions at the institutional level (Damien Cateau, Florent Mace, Anne Niquille)

 

Room 002

W5- Inappropriate prescribing cascades: Identifying and deprescribing the domino effect

(Kieran Dalton, Fatma Karapinar, Lisa McCarthy)

 

Room 003

W6- Deprescribed or discontinued? A lexical question that makes a significant difference for research and clinical practice (Caroline Sirois, Alexandre Campeau Calfat, Emily Reeve, Cynthia Boyd, Justin Turner)

10h30-11h15

Break – Poster session (Bias 1 hall)

 

11h15-12h45

Parallel sessions

 

 

French Symposium

(Main amphi Bias)

          Passé et futur de la déprescription en France (session en français)

 

Oral communication#4 (Room 001)

Technology and medication review to support deprescribing

 

Workshops (Bias 2)

 

 

Room 002

W7- Deprescribing long-term use of antidepressants: strategies for clinical practice (Ellen Van Leuuwen, Hanne Creupelandt, Joke Pauwelyn, Hanna Bowers, Catherine Woods, Tony Kendrick, Thierry Christiaens).

 

Room 003

W8- The role of the private sector in deprescribing: What role should pharmaceutical and biotechnology companies play?  The role of the private sector in deprescribing: What role should pharmaceutical and biotechnology companies play? (Katharina Tabea Jungo, Cynthia Boyd, Caroline McCarthy, Barbara Farrell)

 

Room 004

W9- Innovations and challenges in deprescribing opioids in older people (Gert Baas, Sanne Bakker-Verdoorn, Henk-Frans Kwint)

12h45-13h45

Lunch

 

13h45-15h15

Parallel sessions

 

 

Oral communications #5

Main amphi (Bias 1)

Updates in Measurement Relevant to Deprescribing Evaluations

 

Workshops (Bias 2)

 

 

Room 001

W10- Global Workshop on Engaging Stakeholders in Deprescribing and Age Friendly 4Ms Care

(Nicole Brandt, Robert Wahler, Daniel Mansour, Jennifer Stoll, Catherine Sarkisian, Carmen Reyes, Suvi Hakoinen, Marja S Airaksinen, Mustafa Awad)

 

Room 002

W11- Economic evaluations of deprescribing interventions (Caroline McCarthy, Frank Moriarty)

 

Room 003

W12- Finding the Sweet Spot: Choosing Glycemic Control Wisely for Older Adults with Diabetes (Wade Thompson, Iliana Lega, Lisa McCarthy)

 

Room 004

W13- Développer et mettre en œuvre des activités interprofessionnelles de déprescription au niveau d'une institution (Damien Cateau, Florent Mace, Anne Niquille) (session en français)

15h15-15h30

Break

 

15h30-17h00

Original communications #6

Main amphi (Bias 1)

Evaluations of Deprescribing Interventions Around the Globe

17h00-18h00

Closing session

Main amphi(Bias 1)

Closing speech

Closing keynote: Title tbc (Anne Spinewine, Franck Moriarty)

18h00-18h30

Departure of participants

 

 

 

 

Online user: 3 Privacy
Loading...